Biosimilars in the United States: Unraveling the Path Forward and Lessons Learned from Europe
In this webinar, presenter Sapna Palla, Partner in the Life Sciences Intellectual Property Group, will discuss:
- The pitfalls in the nascent United States biosimilar regulations.
- Recent developments and issues before the Federal Circuit and United States Supreme Court.
- Key differences compared to the European regime and lessons learned.
- Practical tips and considerations for companies in the biosimilars space operating both in the United States and internationally.
To register for this event, click here.